ArticleFrontiers in oncology2022

Lipolysis-Stimulated Lipoprotein Receptor Impairs Hepatocellular Carcinoma and Inhibits the Oncogenic Activity of YAP1

Xin Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.